IP Library Granted Patent US 8,512,695
Granted Patent B2
US 8,512,695 · App. 12/603,075 · Granted Aug 20, 2013

Method of preventing fat graft resorption by administering fat-derived cells and poloxamer P 188

Inventor: William G. Austen, Jr. (Weston, MA)
Assignee: The General Hospital Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,512,695
App. No.
12/603,075
Granted
Aug 20, 2013
Kind
B2
Abstract

The present invention provides polymers for use in preventing damage to the membranes of cells in fat grafts. Mixing of a triblock copolymer such as poloxymer P188 with adipocytes or adipose tissue to be transplanted into a subject is thought to stabilize the membranes of the cells leading to more successful fat transplantation in soft tissue reconstruction or augmentation. Such methods may also be used in the transplantation of adult stem cells or other cells derived from fat tissue. Other agents such as lipoic acid may also be added to the polymer/cell compositions for cell transplantation.

Claims (17)

1. A method of preventing the resorption of a fat graft comprising:

(a) administering a composition of fat-derived cells and POLOXAMER P188 to a subject, and

(b) allowing a fat graft derived from the composition to form in the subject,

wherein the POLOXAMER P188 prevents resorption of the fat graft, protects the cells from injury, and prevents cell death.

2. The method of claim 1 , wherein the fat-derived cells are adipocytes.

3. The method of claim 1 , wherein the fat-derived cells are stem cells.

4. The method of claim 1 , wherein the fat-derived cells are autologous cells.

5. The method of claim 1 , wherein the composition of fat-derived cells and POLOXAMER P188 further comprises lipoic acid.

6. The method of claim 1 , wherein the composition comprises about 1 mg to about 20 mg of POLOXAMER P188 per ml of cells.

7. The method of claim 1 , wherein the composition comprises about 5 mg to about 15 mg of POLOXAMER P188 per ml of cells.

8. The method of claim 1 , wherein the composition comprises about 15 mg of POLOXAMER P188 per ml of cells.

9. The method of claim 1 , wherein the composition comprises about 10 mg of POLOXAMER P188 per ml of cells.

10. The method of claim 1 , wherein the POLOXAMER P188 is at least 95% pure.

11. The method of claim 1 , wherein the POLOXAMER P188 is at least 98% pure.

12. The method of claim 1 , wherein the POLOXAMER P188 is at least 99% pure.

13. The method of claim 1 , wherein the subject is a mammal.

14. The method of claim 1 , wherein the subject is a human.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2010
From: AUSTEN, WILLIAM G., JR.
To: THE GENERAL HOSPITAL CORPORATION D/B/A MASSACHUSETTS GENERAL HOSPITAL
Reel/Frame 023757/0222 →
Continuity (2)
Provisional Application 61107023 · Oct 21, 2008
Related Publication 20100104542A1 · Apr 29, 2010